About: Saratoga Opthalmology

Posts by Saratoga Opthalmology:

Infants may not benefit from IOL implantation

This literature review compared the safety and visual outcomes associated with optical correction using an IOL, contact lenses or spectacles after cataract surgery in children 2 years of age or younger. Source: AAO

Posted on: Oct 25 2019
By: Saratoga Opthalmology
Leave a reponse

Macula-off retinal detachment may be more urgent than previously thought

This study examines whether final visual acuity (VA) is influenced by the duration of macular detachment. Source: AAO

Posted on: Oct 24 2019
By: Saratoga Opthalmology
Leave a reponse

Fractionated conformal radiotherapy has lasting effects for optic nerve sheath meningioma

This study assesses the long-term effectiveness of fractionated conformal radiotherapy for the management of primary optic nerve sheath meningioma. Source: AAO

Posted on: Oct 23 2019
By: Saratoga Opthalmology
Leave a reponse

Infliximab can lead to remission in children with recalcitrant uveitis

Investigators describe the use of infliximab in pediatric patients with noninfectious uveitis who failed to respond to adalimumab. Source: AAO

Posted on: Oct 22 2019
By: Saratoga Opthalmology
Leave a reponse

Orasis’ presbyopia eyedrop meets primary endpoint in phase 2b trial

A corrective eyedrop for presbyopia is progressing through the regulatory pipeline as encouraging findings emerge from a phase 2b study. Source: AAO

Posted on: Oct 22 2019
By: Saratoga Opthalmology
Leave a reponse

Biometry measurements altered by epithelial basement membrane dystrophy and Salzmann nodular degeneration

This retrospective review examines how optical biometry measurements are influenced by epithelial basement membrane dystrophy and Salzmann nodular degeneration. Source: AAO

Posted on: Oct 21 2019
By: Saratoga Opthalmology
Leave a reponse

Do adverse events during anti-PD-1 therapy correlate with tumor mutational burden?

This retrospective study assessed the relationship between serious immune-related adverse events during anti-PD-1 cancer therapy and tumor mutational burden. Source: AAO

Posted on: Oct 17 2019
By: Saratoga Opthalmology
Leave a reponse

Experimental duel angiogenic inhibitor outperforms ranibizumab for DME

This phase 2 study reports the safety and efficacy of faricimab for diabetic macular edema (DME). Source: AAO

Posted on: Oct 16 2019
By: Saratoga Opthalmology
Leave a reponse

Women, younger patients most likely to heed follow-up advice

Investigators identified patient characteristics associated with follow-up compliance after cataract surgery. Source: AAO

Posted on: Oct 10 2019
By: Saratoga Opthalmology
Leave a reponse

Hydrus microstent shows promising efficacy at 2 years

Investigators assessed the safety and efficacy of Schlemm canal stenting in combination with cataract surgery in eyes with mild to moderate primary open-angle glaucoma (POAG). Source: AAO